CCO Independent Conference Coverage

2008 San Antonio Breast Cancer Symposium*

December 10-14, 2008 | San Antonio, Texas

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Early Breast Cancer

Track 1 of 3

Capsule Summaries

Expert Analysis

Moderator: Robert S. Mocharnuk, MD

Faculty:
		Harold J. Burstein, MD, PhD Peter Ravdin, MD, PhD Hope S. Rugo, MD

Metastatic Breast Cancer

Track 2 of 3

Capsule Summaries

Expert Analysis

Moderator: Richard Finn, MD

Faculty:
		Clifford A. Hudis, MD Kathy D. Miller, MD Joyce O’Shaughnessy, MD

Prediction and Prognosis

Track 3 of 3

Capsule Summaries

Expert Analysis

Moderator: Jeffrey B. Smerage, MD, PhD

Faculty:
		Matthew Ellis, MD, PhD William J. Gradishar, MD, FACP Edith A. Perez, MD

CCO Slideset

Breast Cancer: Highlights CCO Independent Conference Coverage of the 2008 San Antonio Breast Cancer Symposium

Downloadable slideset highlighting some of the most significant data presented in the adjuvant and metastatic settings as well as studies focused on predictive and prognostic factors.

Format: Microsoft PowerPoint (.ppt) | File size: 3.41 MB | Date posted: 1/22/2009

Expert Highlights

	William J. Gradishar, MD, FACP, discusses key studies presented on molecular markers and tools for predicting treatment benefit in breast cancer patients. (9 minutes)		Download Audio
	Kathy D. Miller, MD, reviews the top studies presented for the treatment of metastatic breast cancer including the use of mTOR inhibitors, HDAC inhibitors, antiangiogenic agents, and hormonal therapies. (10 minutes)		Download Audio
	Hope S. Rugo, MD, discusses the highlights of presentations on early breast cancer, including hormone therapy, HER2-directed therapy, use of bisphosphonates to prevent bone loss, and adjuvant therapy. (12 Minutes)		Download Audio

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.